Received Sep 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4zs72 | — |
cut finger/sliced the thumb with the glass; Syringe issue; Product complaint; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of laceration of finger in a male patient who received Herpes zoster (Shingrix) (batch number 4zs72, expiry date 26-APR-2025) for prophylaxis. This case was associated with a product complaint. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced laceration of finger (Verbatim: cut finger/sliced the thumb with the glass), syringe issue (Verbatim: Syringe issue) and pharmaceutical product complaint (Verbatim: Product complaint). The outcome of the laceration of finger, syringe issue and pharmaceutical product complaint were not applicable. It was unknown if the reporter considered the syringe issue to be related to Shingrix. It was unknown if the company considered the syringe issue to be related to Shingrix. Additional Information: GSK receipt date: 08-AUG-2025 This Product Quality complaint was regarding Shingrix. Other HCP was giving Shingrix vaccines at pharmacy day before reporting and went to pop the top plastic cap off and the neck of the vial broke and shattered the glass. Reporter would like to see if they can get a replacement diluent for the Shingrix vaccine.